Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05213000 · ClinicalTrials.gov registry record · NA
Adjuvant Effect of Physical Exercise on Immune Response to COVID-19 Vaccination and Interactions With Stress
A NA study of Immunization, sponsored by Iowa State University.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05213000 is a NA study of Immunization that is actively recruiting participants, run by Iowa State University. The registered enrollment target is 80 participants, below the 16,035-participant average among 5 other Immunization trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05213000, a NA study of Immunization, is actively recruiting participants, sponsored by Iowa State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the extent to which a single session of light to moderate intensity exercise performed within 30 minutes after receiving either the initial dose of COVID-19 mRNA vaccine may modify the immune response to vaccination, and identify potential underlying mechanisms using gene expression and metabolite analysis. A secondary goal is to establish whether psychosocial factors are associated with immune response to vaccination. Participants will be randomized to either a 90-minute light to moderate intensity exercise session or daily routine as usual (no exercise) after receiving their initial COVID-19 mRNA vaccine. If assigned to exercise, the exercise will begin within 30 minutes after receiving the vaccine and will consist of a brisk walk and/or jog supervised by study personnel. Blood will be collected from participants prior the initial dose, two weeks after the initial dose, one week after the second dose if the individual receive the two-dose vaccine regiment or one month after the initial dose if the individual receives a one-dose vaccine regimen, and three, six, and 12 months following the initial dose. . Side effects will be measured for three days post-vaccination. Antibody and cell-mediated immune response to the vaccine will be measured in blood samples. Gene expression profiles will be analyzed by single cell RNA sequencing. Serum metabolites will be assessed to align with immune measures. Participants will be asked to complete surveys to measure physical activity history, psychosocial stress, resilience, and depression. The hypotheses of this study are: 1) a single session of exercise which take place shortly after receiving either the initial dose or the booster dose of COVID-19 will increase antibody and T cell response to the vaccine and will be associated with differentially expressed genes and an altered metabolite profile, and 2) higher levels of reported stress, and lower levels of resilience will be associated w
Conditions Studied
Interventions
- BEHAVIORAL Exercise
Study Locations (1)
Iowa
- Iowa State University - Ames
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05213000
The ClinicalTrials.gov registry entry for NCT05213000 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 16,035-participant average among 5 other Immunization trials with a reported enrollment target (100% lower). The listed sponsor is Iowa State University, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Immunization appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.
NCT05213000 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT05213000 about?
NCT05213000 is a clinical study titled "Adjuvant Effect of Physical Exercise on Immune Response to COVID-19 Vaccination and Interactions With Stress". The purpose of this study is to evaluate the extent to which a single session of light to moderate intensity exercise performed within 30 minutes after receiving either the initial dose of COVID-19 mRNA vaccine may modify the immune response to vaccination, and identify potential underlying mechanis...
What is the current status of trial NCT05213000?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2021-03-01. Estimated completion is 2026-09-30.
What conditions does trial NCT05213000 study?
This clinical trial studies the following conditions: Immunization.
What interventions are being tested in trial NCT05213000?
The interventions under investigation include: Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT05213000?
This trial is sponsored by Iowa State University, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05213000 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Immunization
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Influenza Immunization in Adults Over Age 75
RECRUITING · NA
-
The STOP-HPV Trial 2: Performance Feedback Intervention
COMPLETED · NA
-
State Immunization Information Systems to Improve HPV Vaccination Rates
COMPLETED · NA
-
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
RECRUITING · Phase 4
-
GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.